Lipids in Health and Disease

Table 3 Correlations between biochemical parameters and atherogenic lipoproteins levels

From: Correlation between serum levels of proprotein convertase subtilisin/kexin type 9 (PCSK9) and atherogenic lipoproteins in patients with coronary artery disease

	Lipoprotein(a)				Small, dense LDL				Oxidized LDL
	r	p value	β	p value	r	p value	β	p value	r	p value	β	p value
Age	0.129	0.2			−0.289	0.003	−0.056	0.41	−0.017	0.87
Sex	−0.030	0.77			−0.072	0.48			0.084	0.42
Body mass index	−0.180	0.08	−0.317	0.0009	0.233	0.02	0.028	0.68	−0.066	0.53
Hypertension	0.060	0.55			−0.103	0.31			0.085	0.41
Diabetes	−0.107	0.29			0.160	0.11			−0.100	0.33
Smoking	−0.189	0.06	−0.273	0.004	−0.004	0.97			−0.073	0.48
Total cholesterol	0.196	0.05	−0.241	0.24	0.711	<0.0001	0.209	0.19	0.080	0.44
LDL cholesterol	0.144	0.15			0.611	<0.0001	−0.269	0.22	0.039	0.71
Triglycerides	0.029	0.77			0.585	<0.0001	0.150	0.15	0.053	0.61
HDL cholesterol	0.129	0.2			−0.109	0.28			0.069	0.5
Apolipoprotein A1	0.056	0.58			0.022	0.82			0.047	0.65
Apolipoprotein B	0.260	0.009	0.573	0.007	0.758	<0.0001	0.683	0.005	0.112	0.28
Hetero-dimer PCSK9	0.195	0.05	0.235	0.01	0.336	0.0006	0.143	0.03	0.268	0.008	0.268	0.008
Furin-cleaved PCSK9	0.063	0.53			0.234	0.02			0.026	0.8

Male gender, hypertension, diabetes, and smoking were assigned a value of 1. Female gender, normotension, non-diabetes, and non-smoking were assigned a value of 0
LDL low-density lipoprotein, HDL high-density lipoprotein, PCSK9 proprotein convertase subtilisin/kexin type 9

Back to article page

ISSN: 1476-511X

Contact us

General enquiries: journalsubmissions@springernature.com